Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
Accelerated fractionation radiotherapy and late intensification with 2 intra-arterial cisplatin infusions for locally advanced head and neck squamous cell carcinoma
Head & Neck, 11/04/09
Yu KH et al. – It was feasible to give IAC concurrent with accelerated fractionation radiotherapy for locally advanced HNSCC. The maximum tolerated dose of cisplatin was 125 mg/m2.
Related Articles
Spread of Squamous Cell Carcinoma From the Thumb to the Small Finger via the Flexor Tendon Sheaths
The Journal of Hand Surgery, 11/16/09
Relevance Score: 83%
Squamous cell cancer of the rectum
World Journal of Gastroenterology, 10/01/09
Relevance Score: 82%
Primary cutaneous myxoid spindle cell squamous cell carcinoma: a clinicopathologic study and review of the literature
Journal of Cutaneous Pathology, 10/09/09
Relevance Score: 81%
RalA suppresses early stages of Ras-induced squamous cell carcinoma progression
Oncogene, 10/08/09
Relevance Score: 81%
Nd:YAG laser therapy of carcinoma lip (stage I squamous cell carcinoma): a retrospective evaluation
Indian Journal of Otolaryngology and Head & Neck Surgery, 10/07/09
Relevance Score: 81%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer
Archives of Otolaryngology, 11/25/09
Complications of hydroxyapatite bone cement reconstruction of retrosigmoid craniotomy: Two cases
ENT Journal, 11/25/09
N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09
Article Search
Sponsor


See Latest Articles


